EyePoint, Inc. Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)
EyePoint, Inc. (EYPT) reported Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) of -$169.00 thousand for the 12-month period ending 2012-06-30, per its 10-K filed 2012-09-27.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperations · last filed 2012-09-27
- EyePoint, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2012 was -$169.00K.
- EyePoint, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2011 was -$218.00K, a 1047.83% decline from fiscal 2010.
- EyePoint, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2010 was $23.00K.
| Period end | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-06-30 | -$169.00K 10-K · filed 2012-09-27 |
| 2011-06-30 | -$218.00K 10-K · filed 2012-09-27 |
| 2010-06-30 | $23.00K 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |